50% off the $29.99 Custom Kit. Use at checkout:
⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
Genomic Urine Tests for the Risk Stratification and Rule Out of Bladder Cancer
AEO Score: 5/10
Monitoring for AI engine activity
In the Engagemii AEO index
#136,412 of 457,422 in Healthcare for AI visibility
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Genomic Urine Tests for the Risk Stratification and Rule Out of Bladder Cancer just got measured.
5/10 means Genomic Urine Tests for the Risk Stratification and Rule Out of Bladder Cancer is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
About Genomic Urine Tests for the Risk Stratification and Rule Out of Bladder Cancer
Cxbladder is a suite of easy-to-use and non-invasive tests designed to help rule out urothelial bladder cancer in patients experiencing blood in urine (hematuria) and to monitor for recurrent disease in those who have been treated for non-muscle invasive bladder cancer.
Key Topics
Details
Industry: Healthcare
cxbladder.comAI Visibility Breakdown
4
Structured Data
6
Content Structure
6
Entity Clarity
3
E-E-A-T Signals
7
Technical AEO
4
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
Trust Is the Product. AI Is How You Build It at Scale.
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Genomic Urine Tests for the Risk Stratification and Rule Out of Bladder Cancer.
Source & Attribution
Scored by Engagemii on June 30, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/cxbladder
Cite this score: Engagemii (2026). "AEO Score for Genomic Urine Tests for the Risk Stratification and Rule Out of Bladder Cancer." Retrieved from https://engagemii.com/aeo/brands/cxbladder
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform